Oncimmune Holdings full year results and conference call

DirectorsTalk Interviews

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, states that it will be announcing its full year results for the year ended 31st May 2020 on Friday, 30 October 2020.

Adam Hill, Chief Executive Officer, together with Matthew Hall, Chief Financial Officer, will host a presentation and conference call for analysts at 11:30am GMT on the day of the results.

For conference call details please contact Alexander Davis of FTI Consulting at [email protected] or 020 3727 1000.

The management team will also host on Investor Meet Company a live presentation of the results on Friday, 30 October at 15:00 GMT.

• The online presentation will be open to all existing shareholders and potential new investors.

• Questions can be submitted before the event via your Investor Meet Company dashboard or at any time during the live presentation via the “Ask a Question” function. Responses to the Q&A will be published at the earliest opportunity on the Investor Meet Company platform.

• Investor feedback can also be submitted directly to management immediately following the event.

Access to Investor Meet Company is free and interested parties can register to attend the presentation via the following link: https://www.investormeetcompany.com/essensys-plc/register-investor

Attendees who have already registered on the Investor Meet Company platform to meet the Oncimmune Holdings will automatically receive an invitation to the presentation.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Investors watch UK GDP and US jobs as currency moves tighten

Key UK and US data this week will drive currency moves and reset interest rate expectations.

Diversified Energy gains recognition for sustainability focus

Diversified Energy shortlisted for US IR award recognising ESG alignment and responsible investor engagement.

Dunelm reports solid H1 FY26 sales growth amid challenging market conditions

Dunelm Group plc announced Interim Results for the 26 weeks to 27 December 2025, reporting total sales growth of 3.6% to £926.3m and increased market share despite a softer second quarter.

Bellway reports higher completions and maintains FY26 guidance

Bellway said first-half housing completions rose to 4,702 homes, with revenue up over 6% to £1.51bn, despite softer reservation rates through the autumn.

Verici Dx: Tutivia Set to Disrupt Transplant Monitoring with Real-Time RNA Insights (Video)

Tutivia is turning heads in transplant care. Verici Dx CEO Sara Barrington explains how their RNA-based rejection test is setting new standards in real-world use—and why clinicians and payers are getting on board.

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International.

    Search

    Search